Case Study: Immunomedics achieves effortless remote endpoint protection and malware blocking with Malwarebytes Endpoint Protection

Immunomedics - Customer Case Study

Immunomedics, an antibody-based therapeutics company expanding into a nationwide sales force and working with external research partners, faced a growing attack surface and the challenge of keeping remote endpoints consistently protected. The IT team needed a low-effort, centrally managed solution to ensure endpoints stayed up to date and to safeguard valuable intellectual property and research data from malware and malicious websites.

Immunomedics migrated to cloud-based Malwarebytes Endpoint Protection, using multi-vector, signature-less detection to block malicious sites, stop threats before they execute, and automatically remediate infections. Deployment was quick and simple, and the company gained centralized policy management, consolidated visibility, remote updates, and detailed reporting for audits—resulting in reliable protection, fewer incidents, and simplified endpoint management.

Immunomedics

Brian Padovano

Systems Analyst and Assistant Administrator